Yes, several medical treatments and medications can cause iatrogenic hypogonadism, which is a hormone deficiency induced by medical intervention. While these treatments are often necessary for life saving or chronic care, they can inadvertently damage the testes or disrupt the brain signalling required for testosterone production. In 2026, clinical protocols emphasise the importance of monitoring hormonal health in survivors of cancer and patients on long term pain management to prevent the systemic complications of low testosterone.
What We Will Cover in This Article
- Chemotherapy and its direct impact on testicular cells
- Opioid induced androgen deficiency
- The effect of long term glucocorticoid use
- Radiation therapy and its proximity to the endocrine system
- Reversibility vs permanent damage in 2026
- Clinical monitoring for patients on high risk medications
Chemotherapy and Testicular Damage
Chemotherapy drugs are designed to target rapidly dividing cells. While effective against cancer, they can also attack the healthy cells within the testes.
- Alkylating Agents: Drugs like cyclophosphamide and cisplatin are particularly gonadotoxic. They can cause primary hypogonadism by damaging the Leydig cells, which produce testosterone, and the Sertoli cells, which manage sperm production.
- Treatment Intensity: In 2026, data suggests that the risk of permanent hormone deficiency increases with the dose and duration of treatment. While some men recover their natural levels 6 to 12 months post treatment, high dose regimens can lead to a lifetime of required hormone replacement.
Opioid Induced Androgen Deficiency
One of the most common causes of medication induced hormone problems in 2026 is the long term use of opioid painkillers.
Opioids cause secondary hypogonadism by binding to receptors in the hypothalamus. This suppresses the release of Gonadotropin Releasing Hormone, which in turn stops the pituitary gland from signalling the testes to produce testosterone. Studies show that up to 75 percent of men on long term opioid therapy for chronic pain may be biochemically hypogonadal. Because this is a signalling issue rather than physical damage to the testes, it is often reversible if the opioids are tapered or stopped.
Glucocorticoids and Steroid Use
Glucocorticoids, such as prednisone or dexamethasone, are powerful anti inflammatory medications used for conditions like asthma, rheumatoid arthritis, and inflammatory bowel disease.
When used at high doses or over long periods, glucocorticoids act as a biological brake on the entire hormonal system. They directly suppress the brain signals and can also make the body tissues less responsive to the testosterone that is still being produced. In 2026, clinicians refer to this as steroid induced hypogonadism, a condition that can lead to rapid muscle loss and bone thinning if not identified early.
Radiation Therapy and Endocrine Health
The impact of radiation on testosterone depends entirely on where the radiation is targeted.
- Testicular Radiation: If the testes are directly within the radiation field, such as in certain cases of testicular cancer, it often leads to permanent primary hypogonadism.
- Cranial Radiation: Radiation targeted at the brain, specifically near the pituitary gland or hypothalamus, can disrupt the hormonal master switch, leading to secondary hypogonadism.
Even when the testes are not the primary target, scattered radiation from nearby areas like the pelvis or abdomen can still cause a measurable decline in hormone production.
Other Notable Medications
In clinical practice, we monitor several other classes of drugs that can interfere with male hormones:
- Antifungals: Ketoconazole can directly inhibit the enzymes needed to synthesise testosterone.
- Prostate Cancer Treatments: Hormone deprivation therapies are designed to lower testosterone to near zero levels to starve cancer cells, causing medically induced hypogonadism.
- Anabolic Steroid Misuse: External testosterone use causes the body to shut down its own natural production, which can take months or years to recover.
To Summarise
Many essential medical treatments come with the side effect of suppressing male hormones. Whether through the direct cellular damage of chemotherapy or the signalling interference of opioids and steroids, iatrogenic hypogonadism is a significant clinical reality in 2026. The key to management is early identification. For many, the deficiency is temporary and resolves after treatment ends, but for others, long term support is needed to maintain bone density, muscle mass, and quality of life.
If you are beginning a course of chemotherapy or long term pain management, ask your doctor for a baseline testosterone test to monitor your levels throughout treatment.
Will my testosterone always return to normal after chemotherapy?
Not always. While many younger men see a return of function, older men or those who received very high doses of alkylating agents may experience permanent testicular failure.
Can I take testosterone while on opioids?
Yes. In 2026, testosterone replacement therapy is a common and effective way to manage the side effects of opioid induced deficiency for those who cannot stop their pain medication.
How soon do steroids start lowering testosterone?
A significant drop can be seen within days of starting high dose glucocorticoids, although it usually requires several weeks of use to develop clinical symptoms of hypogonadism.
Does a single round of radiation cause low testosterone?
It depends on the dose and location. Direct radiation to the testes is highly likely to cause a permanent drop, whereas scattered radiation might only cause a temporary dip.
Can hair loss medication like finasteride cause hypogonadism?
Finasteride does not lower testosterone; in fact, it slightly increases it. However, it can cause symptoms similar to low testosterone by interfering with a testosterone derivative called DHT.
Is infertility the same as hypogonadism during treatment?
They are related but different. Chemotherapy often affects sperm production more severely and earlier than it affects testosterone production.
Authority Snapshot
This article was written by the MyPatientAdvice clinical team and reviewed by Dr. Stefan Petrov, a UK trained physician with an MBBS and extensive experience in general medicine, surgery, and emergency care. Dr. Petrov has postgraduate certifications including Basic Life Support (BLS), Advanced Cardiac Life Support (ACLS), and the UK Medical Licensing Assessment (PLAB 1 & 2). He has worked in both hospital wards and intensive care units, performing diagnostic and therapeutic procedures, and has contributed to medical education by creating patient focused health content and teaching clinical skills to junior doctors.
